Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Sumitomo Dainippon to Invest in, Conduct Joint R&D with Cyborg Tech Startup
October 18, 2018
- Nippon Shinyaku Seeks Japan Approval for Hepatic VOD Treatment Defibrotide
October 18, 2018
- Shionogi Launches New Manufacturing Subsidiary, Commencing Operations in April Next Year
October 18, 2018
- Eisai’s Insomnia Treatment Lemborexant Smashes Primary Target in Long-Term PIII Study
October 18, 2018
- Daiichi Sankyo Files Quizartinib for AML in Japan
October 18, 2018
- JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near
October 17, 2018
- Eisai Seals Latin America Pact for Belviq
October 17, 2018
- Teva Takeda Launches Voluntary Recall for Taxotere Generics
October 17, 2018
- Chugai’s Satralizumab Cuts Relapse Risk of Neuromyelitis Optica Spectrum Disorder
October 16, 2018
- Ono Joins GHIT Fund as 21st Funding Partner
October 16, 2018
- China Regulators Accept NDA for Fycompa
October 15, 2018
- Chugai Sues Daiichi Sankyo, Pfizer over Herceptin Biosimilars
October 15, 2018
- Oncodesign Strengthens Its Cooperation with Eisai
October 15, 2018
- Kyorin Begins Collaborative Research on Antibiotics with Microbial Chemistry Research Foundation
October 12, 2018
- Nippon Shinyaku to Expand Contract Manufacturing Biz with New Facility to Start Full Operation in Feb.
October 12, 2018
- Avastin Top-Seller in Japan for 2nd Straight Month in September: Encise Snapshot
October 11, 2018
- Perjeta Gets Japan OK as Neoadjuvant, Adjuvant Therapy for HER2 Breast Cancer
October 11, 2018
- Shonan iPark to Focus on Disease Prevention, 3 Other Areas, Aiming to House 200 Companies by FY2023
October 11, 2018
- Towa’s Allegra Generic Grabs Approval for Expanded Pediatric Use
October 11, 2018
- Opdivo/Yervoy Combo Gets 1st Line RCC Nod in South Korea
October 10, 2018
ページ
The number of newly listed generic drugs in Japan has fallen sharply over the past decade, reflecting structural changes in…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…